BioNexus Gene Lab (BGLC) Competitors $5.22 +0.20 (+3.98%) Closing price 04:00 PM EasternExtended Trading$5.21 -0.01 (-0.21%) As of 05:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock BGLC vs. KDLY, CCM, MGRX, MRAI, BRTX, SSY, ACON, DHAC, NIVF, and BACKShould you be buying BioNexus Gene Lab stock or one of its competitors? The main competitors of BioNexus Gene Lab include Kindly MD (KDLY), Concord Medical Services (CCM), Mangoceuticals (MGRX), Marpai (MRAI), Biorestorative Therapies (BRTX), SunLink Health Systems (SSY), Aclarion (ACON), Digital Health Acquisition (DHAC), NewGenIvf Group (NIVF), and IMAC (BACK). These companies are all part of the "healthcare" industry. BioNexus Gene Lab vs. Its Competitors Kindly MD Concord Medical Services Mangoceuticals Marpai Biorestorative Therapies SunLink Health Systems Aclarion Digital Health Acquisition NewGenIvf Group IMAC Kindly MD (NASDAQ:KDLY) and BioNexus Gene Lab (NASDAQ:BGLC) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, risk, profitability, valuation, earnings and dividends. Does the media prefer KDLY or BGLC? In the previous week, Kindly MD had 1 more articles in the media than BioNexus Gene Lab. MarketBeat recorded 2 mentions for Kindly MD and 1 mentions for BioNexus Gene Lab. BioNexus Gene Lab's average media sentiment score of 1.91 beat Kindly MD's score of 0.81 indicating that BioNexus Gene Lab is being referred to more favorably in the news media. Company Overall Sentiment Kindly MD Positive BioNexus Gene Lab Very Positive Is KDLY or BGLC more profitable? Kindly MD has a net margin of 0.00% compared to BioNexus Gene Lab's net margin of -30.70%. Kindly MD's return on equity of 0.00% beat BioNexus Gene Lab's return on equity.Company Net Margins Return on Equity Return on Assets Kindly MDN/A N/A N/A BioNexus Gene Lab -30.70%-35.54%-29.08% Which has better earnings & valuation, KDLY or BGLC? BioNexus Gene Lab has higher revenue and earnings than Kindly MD. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKindly MD$2.47M3.02-$4.64M-$0.77-1.61BioNexus Gene Lab$9.55M0.98-$1.60MN/AN/A Do institutionals & insiders have more ownership in KDLY or BGLC? 18.9% of BioNexus Gene Lab shares are owned by institutional investors. 50.5% of Kindly MD shares are owned by company insiders. Comparatively, 0.7% of BioNexus Gene Lab shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryKindly MD beats BioNexus Gene Lab on 6 of the 10 factors compared between the two stocks. Get BioNexus Gene Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for BGLC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BGLC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BGLC vs. The Competition Export to ExcelMetricBioNexus Gene LabMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.38M$7.52B$5.70B$10.27BDividend YieldN/A2.80%5.72%4.60%P/E RatioN/A74.3075.8626.51Price / Sales0.9836.08491.12165.50Price / CashN/A24.0725.8129.89Price / Book1.137.8912.846.32Net Income-$1.60M$241.92M$3.28B$270.51M7 Day Performance18.37%0.59%0.22%2.15%1 Month Performance-2.25%3.32%4.61%6.35%1 Year Performance17.57%2.55%68.33%25.49% BioNexus Gene Lab Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BGLCBioNexus Gene Lab0.6097 of 5 stars$5.22+4.0%N/A+25.5%$9.38M$9.55M0.0030KDLYKindly MDN/A$4.56+11.8%N/A+118.9%$27.46M$2.47M-5.92N/AGap DownHigh Trading VolumeCCMConcord Medical Services1.3541 of 5 stars$5.55-4.1%N/A+8.0%$25.07M$52.60M0.00970Short Interest ↓Gap DownMGRXMangoceuticals0.6791 of 5 stars$2.30-3.0%N/A-96.5%$24.97M$620K-0.603Short Interest ↑MRAIMarpaiN/A$1.25-2.3%N/A+137.3%$21.59M$34.87M-0.47150Gap DownBRTXBiorestorative Therapies2.3849 of 5 stars$1.57-2.5%N/A-10.7%$12.85M$605.20K-1.247Positive NewsSSYSunLink Health SystemsN/A$1.12+16.6%N/A+43.5%$7.88M$31.09M4.661,376Gap UpACONAclarion2.5887 of 5 stars$7.08-0.3%$11,758.50+166,004.0%-99.5%$4.13M$50K0.007Positive NewsDHACDigital Health AcquisitionN/A$0.67-0.2%N/A-56.4%$2.41MN/A0.002,021NIVFNewGenIvf GroupN/A$1.96+7.4%N/A-99.7%$1.58M$5.43M0.00N/ABACKIMACN/A$0.08+13.9%N/A-94.0%$170K$72.05K0.00180Negative NewsGap Up Related Companies and Tools Related Companies KDLY Alternatives CCM Alternatives MGRX Alternatives MRAI Alternatives BRTX Alternatives SSY Alternatives ACON Alternatives DHAC Alternatives NIVF Alternatives BACK Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BGLC) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersFanatics Hit $31B-Is This Nasdaq Next?Fanatics built an empire by owning the fan experience-scaling to a $31B valuation. But the next wave isn't abo...i2i Marketing Group, LLC | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredOpenAI’s new $300 billion dealOpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next Cha...Porter & Company | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNexus Gene Lab Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNexus Gene Lab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
